Exploring how metal clusters in enzymes can improve chemical synthesis
Multimetallic Catalysis in Biology and Synthesis
This study is exploring how natural metal clusters in certain enzymes help speed up important chemical reactions, with the goal of creating better and greener catalysts that could improve drug development and benefit the environment, ultimately helping patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Chicago NIH-funded |
| Lab location | 1 site (Chicago, UNITED STATES) |
| Project ID | NIH-11092878 on NIH RePORTER |
What this research studies
This research investigates the role of natural multimetallic clusters in metalloenzymes, which are crucial for catalyzing reactions involving small gaseous molecules like carbon dioxide and nitrous oxide. By understanding these clusters, the research aims to develop synthetic multimetallic catalysts that can enhance chemical synthesis, particularly in pharmaceutical applications. The approach includes mapping the reactivity patterns of these clusters and applying this knowledge to create more effective catalysts that are environmentally friendly and sustainable. Patients may benefit indirectly through advancements in drug development and environmental health.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals who rely on pharmaceuticals for treatment and those concerned about environmental health impacts.
Not a fit: Patients who are not involved in pharmaceutical treatments or are not affected by environmental health issues may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more efficient and sustainable methods for drug synthesis, ultimately improving patient access to medications.
How similar studies have performed: Other research has shown promise in using metal clusters for catalysis, indicating that this approach has potential for success.
Where this research is happening
Chicago, UNITED STATES
- University of Illinois at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Mankad, Neal P — University of Illinois at Chicago
- Study coordinator: Mankad, Neal P
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.